南米および中米の変形性関節症治療市場の2030年までの予測 - 地域分析 - 治療タイプ別(経皮的電気神経刺激(TENS)、作業療法、理学療法、多血小板血漿療法および間質血管分画、プロロセラピーなど)、疾患適応症別(膝関節症、脊椎関節症、足関節症および足首関節症、肩関節症、手関節症など)、およびエンドユーザー別(病院および診療所、専門診療所、外来手術センター、在宅ケアなど)

BMIRE00030556 | Pages: 90 | Medical Device | Jul 2024 | Type: Regional | Status: Published
南米および中米の変形性関節症治療市場は、2022年に3億4,544万米ドルと評価され、2030年までに5億5,240万米ドルに達すると予想されており、2022年から2030年にかけて6.0%のCAGRを記録すると推定されています。

より効果的な治療オプションが南米および中米の変形性関節症治療市場を活性化

現在、OAを治す方法はありません。臨床研究科学者のグループは、臨床試験を通じて、OAの進行を止めることができる革新的な治療ターゲットオプションを開発していることを明らかにしています。たとえば、2021年11月、LG Chem社は関節炎を治療するための次世代新薬の臨床試験の開始を発表しました。さらに、2021年10月、Pacira BioSciences、Inc.は、非オピオイド鎮痛剤「ZILRETTA」を治療するためのFlexion Therapeuticsの買収を発表しました。 2017年に承認されたこの薬は、徐放性マイクロスフィア技術を利用したOA膝痛の最初で唯一の承認済み治療薬です。

2023年9月、Sorrento Therapeutics, Inc.は、「Resiniferatoxin(RTX)プログラム」の第2相臨床試験で肯定的な結果を発表しました。第2相試験は、中等度から重度のOAK患者の疼痛管理におけるRTXの複数の投与群の有効性と安全性を評価する多施設、二重盲検、プラセボ、および実薬対照試験です。また、Sorrentoは、現在の臨床試験プロトコルに、承認済みの競合薬「Zilretta」を含めることを決定しました。

南米および中米の変形性関節症治療市場の概要

南米および中米諸国は、ブラジル、アルゼンチン、および南米および中米のその他の国で構成されています。競争の激しい市場で先頭に立つためにメーカーが新製品を発売することは、南米および中米地域の市場成長の重要な要因です。 Researchgate のレポートによると、ブラジルでは 25 歳以上の人の 33% が変形性関節症に罹患しており、推定 4,000 万人がこの疾患に苦しんでいます。さらに、韓国膝協会のレポートでは、ブラジルの成人人口の約 4% が変形性関節症に罹患していることが明らかにされています。競争の激しい市場で先頭に立つためにメーカーが発売する新製品は、市場の成長を牽引する重要な要素です。たとえば、2018 年 10 月、Bioventus は Agência Nacional de Vigilância Sanitária (ANVISA) による「DUROLANE」の承認を発表しました。新しく発売されたこの製品は、ブラジルでの OA 治療用の単回注射剤です。ANVISA は、軽度から中等度の膝および股関節 OA の対症療法として DUROLANE を承認しました。したがって、ブラジルでの変形性関節症治療用の革新的な製品の発売が市場の成長を後押ししています。

南米および中米の変形性関節症治療市場の収益と 2030 年までの予測 (百万米ドル)

南米および中米の変形性関節症治療市場のセグメンテーション

南米および中米の変形性関節症治療市場は、治療タイプ、疾患の適応症、エンド ユーザー、および国に分類されています。

治療タイプに基づいて、南米および中米の変形性関節症治療市場は、経皮的電気神経刺激 (TENS)、作業療法、理学療法、血小板濃縮血漿 (PRP) 療法および間質血管分画、プロロセラピー、その他に分類されています。理学療法セグメントは2022年に最大の市場シェアを占めました。

疾患の適応症では、南米および中米の変形性関節症治療市場は、膝関節症、脊椎関節症、足および足首関節症、肩関節症、手の関節症、その他に分類されています。膝関節症セグメントは、2022年に南米および中米で最大のシェアを占めました。

エンドユーザーに基づいて、南米および中米の変形性関節症治療市場は、病院と診療所、専門診療所、外来手術センター、在宅ケアなどに分類されています。在宅ケアセグメントは、2022年に南米および中米で最大のシェアを占めました。

国別に見ると、南米および中米の変形性関節症治療市場は、ブラジル、アルゼンチン、その他の南米および中米に分類されています。 2022年、南米および中米のシェアはブラジルが独占しました。

Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、およびOmron Healthcare Incは、南米および中米の変形性関節症治療市場で事業を展開している大手企業の一部です。

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 Pipeline Analysis

4.1.1 Clinical Trial Pipeline Analysis

5. South & Central America Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Osteoarthritis

5.1.2 Innovative Therapy Options Reducing Dependency on Medications

5.2 Market Restraints

5.2.1 Product Recall

5.3 Market Opportunities

5.3.1 Availability of Regenerative Medicine

5.4 Future Trends

5.4.1 More Effective Treatment Options

5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - South & Central America Market Analysis

6.1 Overview

6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. South & Central America Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview

7.2 Transcutaneous Electrical Nerve Stimulation (TENS)

7.2.1 Overview

7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Occupational Therapy

7.3.1 Overview

7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Physical Therapy

7.4.1 Overview

7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction

7.5.1 Overview

7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Prolotherapy

7.6.1 Overview

7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview

8.2 Knee Osteoarthritis

8.2.1 Overview

8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Spine Osteoarthritis

8.3.1 Overview

8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Foot and Ankle Osteoarthritis

8.4.1 Overview

8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Shoulder Osteoarthritis

8.5.1 Overview

8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Hand Osteoarthritis

8.6.1 Overview

8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview

9.2 Hospitals and Clinics

9.2.1 Overview

9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Specialty Clinics

9.3.1 Overview

9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Ambulatory Surgical Centers

9.4.1 Overview

9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Homecare

9.5.1 Overview

9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Osteoarthritis Therapy Market - Country Analysis

10.1 South & Central America Market Overview

10.1.1 South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country

10.1.1.1 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 Brazil: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.1.4 Brazil: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.1.5 Brazil: Osteoarthritis Therapy Market Breakdown, by End User

10.1.1.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Argentina: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.2.4 Argentina: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.2.5 Argentina: Osteoarthritis Therapy Market Breakdown, by End User

10.1.1.3 Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 Rest of South & Central America: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.3.4 Rest of South & Central America: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.3.5 Rest of South & Central America: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in the osteoarthritis therapy market

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 Zimmer Biomet Holdings Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 DePuy Synthes Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Bioventus Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Omron Healthcare Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

13. Appendix

13.1 About the Insight Partners

List of Tables

Table 1. Osteoarthritis Therapy Market Segmentation

Table 2. Ongoing Clinical Trial of Osteoarthritis

Table 3. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 4. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 5. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 6. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 7. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 8. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 9. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 10. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 11. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 12. Organic Developments Done by Companies

Table 13. Inorganic Developments Done by Companies

List of Figures

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country

Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)

Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)

Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)

Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. South & Central America: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)

Figure 26. South & Central America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 27. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 29. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 30. Growth Strategies in the Osteoarthritis Therapy Market

1. Zimmer Biomet Holdings Inc 
2. DePuy Synthes Inc 
3. Bioventus Inc 
4. Omron Healthcare Inc 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America osteoarthritis therapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America osteoarthritis therapy market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440